Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 11 | 2024 | 3610 | 1.990 |
Why?
|
Myelodysplastic Syndromes | 4 | 2023 | 1393 | 0.900 |
Why?
|
Antibodies, Bispecific | 2 | 2024 | 196 | 0.880 |
Why?
|
Hemophilia A | 2 | 2024 | 360 | 0.830 |
Why?
|
Trisomy | 1 | 2024 | 260 | 0.820 |
Why?
|
Myeloproliferative Disorders | 2 | 2024 | 611 | 0.690 |
Why?
|
Hemostatics | 1 | 2022 | 241 | 0.680 |
Why?
|
Erythroid Cells | 1 | 2021 | 238 | 0.670 |
Why?
|
Sulfonamides | 6 | 2024 | 1973 | 0.660 |
Why?
|
Mycoses | 1 | 2022 | 386 | 0.630 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 269 | 0.530 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 664 | 0.510 |
Why?
|
Stem Cell Factor | 1 | 2015 | 195 | 0.480 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5663 | 0.450 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2024 | 11729 | 0.410 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2015 | 727 | 0.380 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1874 | 0.370 |
Why?
|
Bone Marrow | 1 | 2021 | 2907 | 0.370 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13616 | 0.350 |
Why?
|
Patient Selection | 1 | 2020 | 4240 | 0.310 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2024 | 929 | 0.270 |
Why?
|
Thrombosis | 1 | 2020 | 2940 | 0.270 |
Why?
|
Blast Crisis | 2 | 2024 | 101 | 0.260 |
Why?
|
Factor VIII | 2 | 2024 | 349 | 0.230 |
Why?
|
Colonic Neoplasms | 1 | 2015 | 2529 | 0.210 |
Why?
|
Cytarabine | 2 | 2024 | 697 | 0.210 |
Why?
|
Karyotyping | 1 | 2024 | 1171 | 0.200 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2020 | 422 | 0.190 |
Why?
|
Remission Induction | 2 | 2024 | 2394 | 0.180 |
Why?
|
Ohio | 1 | 2021 | 322 | 0.180 |
Why?
|
Fibrinogen | 2 | 2020 | 889 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 3 | 2023 | 5662 | 0.170 |
Why?
|
Janus Kinase 2 | 1 | 2023 | 544 | 0.170 |
Why?
|
Cell Proliferation | 1 | 2015 | 10425 | 0.160 |
Why?
|
Signal Transduction | 3 | 2023 | 23397 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17854 | 0.140 |
Why?
|
HCT116 Cells | 2 | 2015 | 401 | 0.140 |
Why?
|
Humans | 26 | 2024 | 760437 | 0.140 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 350 | 0.140 |
Why?
|
Antifungal Agents | 1 | 2022 | 751 | 0.140 |
Why?
|
Mutation | 6 | 2024 | 30025 | 0.140 |
Why?
|
Heparin | 2 | 2021 | 1633 | 0.140 |
Why?
|
Prognosis | 5 | 2024 | 29551 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2024 | 1051 | 0.130 |
Why?
|
Psychoses, Substance-Induced | 1 | 2016 | 99 | 0.120 |
Why?
|
HT29 Cells | 1 | 2015 | 192 | 0.120 |
Why?
|
Caco-2 Cells | 1 | 2015 | 364 | 0.120 |
Why?
|
Autocrine Communication | 1 | 2015 | 169 | 0.120 |
Why?
|
Prospective Studies | 3 | 2023 | 54339 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 996 | 0.110 |
Why?
|
Paracrine Communication | 1 | 2015 | 276 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 1 | 2023 | 1463 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2024 | 80430 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2860 | 0.110 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15476 | 0.110 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4808 | 0.100 |
Why?
|
Molecular Targeted Therapy | 1 | 2023 | 2805 | 0.100 |
Why?
|
Middle Aged | 10 | 2024 | 220382 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1890 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2020 | 1588 | 0.090 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1824 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1297 | 0.090 |
Why?
|
Anticoagulants | 3 | 2021 | 4806 | 0.090 |
Why?
|
Intensive Care Units | 2 | 2021 | 3742 | 0.090 |
Why?
|
Hedgehog Proteins | 1 | 2014 | 768 | 0.090 |
Why?
|
DNA Methylation | 1 | 2024 | 4383 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5794 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2024 | 2911 | 0.080 |
Why?
|
RNA Interference | 2 | 2015 | 2832 | 0.080 |
Why?
|
Cannabis | 1 | 2016 | 437 | 0.080 |
Why?
|
Adult | 10 | 2024 | 220781 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1887 | 0.080 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1753 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8826 | 0.070 |
Why?
|
Immunotherapy | 1 | 2023 | 4649 | 0.070 |
Why?
|
Aged | 8 | 2024 | 168840 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58859 | 0.070 |
Why?
|
Transfection | 1 | 2015 | 5776 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3590 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2563 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4116 | 0.070 |
Why?
|
Male | 10 | 2024 | 360035 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12969 | 0.060 |
Why?
|
Daunorubicin | 1 | 2024 | 156 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18379 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2014 | 2978 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
Risk Assessment | 2 | 2022 | 23953 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2024 | 64591 | 0.050 |
Why?
|
Female | 8 | 2024 | 391875 | 0.050 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7597 | 0.050 |
Why?
|
Prothrombin Time | 1 | 2020 | 117 | 0.040 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2023 | 495 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2020 | 203 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 411 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8519 | 0.040 |
Why?
|
Young Adult | 2 | 2024 | 59068 | 0.040 |
Why?
|
Enoxaparin | 1 | 2020 | 391 | 0.040 |
Why?
|
Ferritins | 1 | 2020 | 597 | 0.040 |
Why?
|
Adolescent | 2 | 2024 | 88196 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1741 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2023 | 2049 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22083 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 39947 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1906 | 0.030 |
Why?
|
Hemorrhage | 1 | 2024 | 3414 | 0.030 |
Why?
|
Risk Factors | 1 | 2019 | 74055 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2024 | 4168 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12698 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3822 | 0.020 |
Why?
|
Mice | 1 | 2015 | 81402 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4567 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2911 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1863 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5966 | 0.020 |
Why?
|
Binding Sites | 1 | 2014 | 6042 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4277 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5778 | 0.010 |
Why?
|
Animals | 1 | 2015 | 168253 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15820 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9340 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21322 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17639 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41366 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16945 | 0.010 |
Why?
|
United States | 1 | 2024 | 72202 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6894 | 0.010 |
Why?
|
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_